Documents
Application Sponsors
BLA 761054 | SAMSUNG BIOEPIS CO LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 100MG | 0 | RENFLEXIS | INFLIXIMAB-ABDA |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2017-04-21 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2019-03-21 | STANDARD |
EFFICACY; Efficacy | SUPPL | 9 | AP | 2019-06-26 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 29 | AP | 2022-01-27 | N/A |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 4 | Null | 15 |
SUPPL | 9 | Null | 7 |
CDER Filings
SAMSUNG BIOEPIS CO LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 761054
[companyName] => SAMSUNG BIOEPIS CO LTD
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761054s009lbl.pdf#page=52"]
[products] => [{"drugName":"RENFLEXIS","activeIngredients":"INFLIXIMAB-ABDA","strength":"100MG","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"06\/26\/2019","submission":"SUPPL-9","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761054s009lbl.pdf\"}]","notes":""},{"actionDate":"03\/21\/2019","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761054s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/21\/2017","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761054Orig1s000lbledt.pdf\"}]","notes":""},{"actionDate":"04\/21\/2017","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761054Orig1s000TOC.cfm\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/21\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761054Orig1s000TOC.cfm\"},{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761054Orig1s000lbledt.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/761054Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2017\\\/761054Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"06\/26\/2019","submission":"SUPPL-9","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761054s009lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761054Orig1s009ltr.pdf\"}]","notes":">"},{"actionDate":"03\/21\/2019","submission":"SUPPL-4","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761054s004lbl.pdf\"}]","notes":">"}]
[actionDate] => 2019-06-26
)
)